CHARM Therapeutics is a biotechnology company focused on developing next-generation precision oncology treatments, specifically targeting acute myeloid leukemia (AML). Utilizing its proprietary AI-driven drug discovery platform, DragonFold, CHARM is advancing a novel menin inhibitor designed to overcome resistance mutations that limit the efficacy of first-generation therapies. The company's innovative approach aims to provide more durable and effective treatment options for AML patients, with clinical development of its lead candidate expected to commence in early 2026. Based in Cambridge and London, CHARM is supported by a strong syndicate of international investors.
Leadership & Board
Current Number of Employees30
Current LinkedIn Followers13,352
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$80M
Total Amount Raised$80M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$80M
Latest Funding Amount$80M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
CHARM Therapeutics had 30 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
30Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
CHARM Therapeutics had 13,352 followers as of October 5, 2026. The number of followers increased by 18 (0.13%) week-over-week.
13,352Latest Followers Count
18(0.13%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.